Dr. Alan Boyd Lumsden, Medical Director, Methodist DeBakey Heart & Vascular Center
Alan Boyd Lumsden, MD
Celebrating Heart Awareness Month February 2016
ALAN LUMSDEN, MD
HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER
Dr. Alan Lumsden received his medical degree with honors from the University of Edinburgh, Scotland in 1981. He completed his internship in General Surgery at the Royal Infirmary of Edinburgh. He then moved to the United States, completing his General Surgery residency, clinical and research fellowships in Vascular Surgery at Emory University School of Medicine in Atlanta, Georgia.
In 1991, Dr. Lumsden accepted a position as an Assistant Professor of Surgery in the Department of Surgery at Emory University School of Medicine. In 1998, Dr. Lumsden became Director of the EmoryEndovascular Training Center and the Emory Venous Clinic in Atlanta. He was appointed Head of General Vascular Surgery at Emory University School of Medicine in March 1999, where he served until November 2001. In December 2001 Dr. Lumsden was named Professor and Chief, Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine. In, January 2008, Dr. Lumsden was named Professor and Chairman, Department of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center and in January 2009, Dr. Lumsden was named Medical Director of the Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas.
Dr. Lumsden has developed an international reputation as a leader in the field of endovascular surgery. His work has resulted in numerousscientific articles, abstracts, books, book chapters and presentations.
Dr. Lumsden’s clinical expertise is in stent graft treatment of thoracic and abdominal aortic aneurysmal disease, stenting and endarterectomy in carotid arterial disease, renovascular hypertension, aortoialicocclusive disease, mesenteric vascular and minimally invasive therapy in venous disease. His research interests are in restenosis and developing newer methods of minimally invasive therapy.